These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 25041461
1. The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects. Erdozain AM, Rubio M, Valdizan EM, Pazos A, Meana JJ, Fernández-Ruiz J, Alexander SP, Callado LF. Addict Biol; 2015 Jul; 20(4):773-83. PubMed ID: 25041461 [Abstract] [Full Text] [Related]
11. Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex. Long LE, Lind J, Webster M, Weickert CS. BMC Neurosci; 2012 Jul 24; 13():87. PubMed ID: 22827915 [Abstract] [Full Text] [Related]
12. Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice. Ghosh S, Kinsey SG, Liu QS, Hruba L, McMahon LR, Grim TW, Merritt CR, Wise LE, Abdullah RA, Selley DE, Sim-Selley LJ, Cravatt BF, Lichtman AH. J Pharmacol Exp Ther; 2015 Aug 24; 354(2):111-20. PubMed ID: 25998048 [Abstract] [Full Text] [Related]
13. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Starowicz KM, Cristino L, Matias I, Capasso R, Racioppi A, Izzo AA, Di Marzo V. Obesity (Silver Spring); 2008 Mar 24; 16(3):553-65. PubMed ID: 18239598 [Abstract] [Full Text] [Related]
14. Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides. Vinod KY, Kassir SA, Hungund BL, Cooper TB, Mann JJ, Arango V. J Psychiatr Res; 2010 Jul 24; 44(9):591-7. PubMed ID: 20015515 [Abstract] [Full Text] [Related]
15. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Chanda PK, Gao Y, Mark L, Btesh J, Strassle BW, Lu P, Piesla MJ, Zhang MY, Bingham B, Uveges A, Kowal D, Garbe D, Kouranova EV, Ring RH, Bates B, Pangalos MN, Kennedy JD, Whiteside GT, Samad TA. Mol Pharmacol; 2010 Dec 24; 78(6):996-1003. PubMed ID: 20855465 [Abstract] [Full Text] [Related]
16. Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase. Navia-Paldanius D, Aaltonen N, Lehtonen M, Savinainen JR, Taschler U, Radner FP, Zimmermann R, Laitinen JT. Eur J Pharm Sci; 2015 Sep 18; 77():180-8. PubMed ID: 26070239 [Abstract] [Full Text] [Related]
17. Classics in Neuroimaging: Imaging the Endocannabinoid Pathway with PET. Varlow C, Boileau I, Wey HY, Liang SH, Vasdev N. ACS Chem Neurosci; 2020 Jul 01; 11(13):1855-1862. PubMed ID: 32559067 [Abstract] [Full Text] [Related]
18. Immunolocalization of cannabinoid receptor 1 (CB1), monoglyceride lipase (MGL) and fatty-acid amide hydrolase 1 (FAAH) in the pig claustrum. Pirone A, Lazzarini G, Lenzi C, Giannessi E, Miragliotta V. J Chem Neuroanat; 2020 Nov 01; 109():101843. PubMed ID: 32599254 [Abstract] [Full Text] [Related]
19. Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity. Hill MN, Barr AM, Ho WS, Carrier EJ, Gorzalka BB, Hillard CJ. J Neurochem; 2007 Oct 01; 103(1):47-56. PubMed ID: 17561935 [Abstract] [Full Text] [Related]
20. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels. Petrosino S, Di Marzo V. Curr Opin Investig Drugs; 2010 Jan 01; 11(1):51-62. PubMed ID: 20047159 [Abstract] [Full Text] [Related] Page: [Next] [New Search]